Home LiteratureArticle Details
PMID: 15341999 Published · ppublish English Journal Article Review

Heterologous immunity and homeostatic proliferation as barriers to tolerance.

Current opinion in immunology ·Vol. 16 ·No. 5 ·2004-10-00 ·Pages 558-64

Taylor DK, Neujahr D, Turka LA

Abstract

The different threshold of activation for memory T cells compared to that of naïve T cells makes them resistant to immunomodulation, thus representing a barrier to tolerance. Recently it has been demonstrated that homeostatic proliferation and heterologous immunity represent two naturally occurring and distinct processes that can generate memory T cells. Homeostatic proliferation refers to the process by which, in a lymphodeficient host, normal T cells 'spontaneously' proliferate in response to self-MHC-peptide complexes. Heterologous immunity refers to a process in which a response to one or more infectious agents generates effector/memory T cells with cross-reactive specificities. Recent new studies have defined the importance of these processes in transplantation models and implicated strategies to induce transplantation tolerance.

MeSH Terms
Animals Autoantigens/immunology Cell Proliferation Graft Rejection/immunology Humans Immune Tolerance Immunologic Memory T-Lymphocytes/immunology
Chemicals
Autoantigens
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Taylor Devon K
University of Pennsylvania, 700 Clinical Research Building, 415 Curie Boulevard, Philadelphia 19104-6144, USA.
Neujahr David
Turka Laurence A
Article Info
Journal
Current opinion in immunology
Abbr.
Curr Opin Immunol
ISSN
0952-7915
Published
2004-10-00
Pages
558-64
Language
English
Region
England
NLM ID
8900118
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com